MedPath

Optimizing PrEP Uptake and Adherence Among Male Sex Workers

Not Applicable
Recruiting
Conditions
Prevention
Interventions
Behavioral: Stage 1 Strength Based Case Management (SBCM) Condition
Behavioral: Stage 2 PrEPare for Work Intervention Condition
Registration Number
NCT05736614
Lead Sponsor
Brown University
Brief Summary

"PrEPare for Work" is a randomized controlled trial (RCT) whose goal is to test the efficacy of a behavioral intervention (Short Title: PrEPare for Work) in improving PrEP uptake, adherence, and persistence among male sex workers (MSW)

Detailed Description

A theory-based, manualized intervention -called "PrEPare for Work"-includes two separate but complementary interventions that address MSW-specific behavioral, economic, interpersonal \& structural-level barriers to accessing and adhering to PrEP: 1) peer-led, strengths-based case management (SBCM) for PrEP linkage and uptake; and 2) a technology and counseling intervention to optimize PrEP adherence (once they have access to PrEP). This research will test the PrEPare for Work intervention in a fully-powered RCT to assess efficacy and cost-effectiveness.

Recruitment & Eligibility

Status
RECRUITING
Sex
Male
Target Recruitment
500
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Stage 1 Strength Based Case Management (SBCM) ConditionStage 1 Strength Based Case Management (SBCM) ConditionIntervention participants will receive a trained SBCM to motivate, support, and assist in linkage to PrEP prescribers to help facilitate obtaining PrEP medication to initiate treatment.
Stage 2 PrEPare for Work Intervention ConditionStage 2 PrEPare for Work Intervention ConditionIntervention participants will receive 1-on-1 adherence counseling and personalized daily text messaging reminders to increase PrEP adherence. Intervention participants will undergo three adherence intervention sessions (once per week for 3 weeks) with interventionist.
Primary Outcome Measures
NameTimeMethod
Stage one: PrEP initiation2-month post Stage 1 randomization

Stage one: PrEP initiation will be measured via verification of prescription filled within two months post-randomization, associated medical records from a PrEP prescriber, and self-report.

Stage two: PrEP adherence12-month post Stage 2 randomization

Stage two: PrEP adherence will be measured via tenofovir concentration in hair. Self-reported adherence will supplement biological monitoring data at 4-month intervals.

Secondary Outcome Measures
NameTimeMethod
PrEP persistence12-month post Stage 2 randomization

PrEP persistence will be measured via medical records and self-report. We will assess PrEP persistence using medical and pharmacy records to confirm provider follow-up visits and prescription refill maintenance. As per Coy et al., PrEP persistence will be defined as having โ‰ฅ16 days of PrEP medication filled per 30-day period, for at least three-quarters of the months since initiation to study completion (\~9 months).

Trial Locations

Locations (5)

UCLA Fielding School of Public Health

๐Ÿ‡บ๐Ÿ‡ธ

Los Angeles, California, United States

The Miriam Hospital

๐Ÿ‡บ๐Ÿ‡ธ

Providence, Rhode Island, United States

Open Door Health

๐Ÿ‡บ๐Ÿ‡ธ

Providence, Rhode Island, United States

Project Weber/RENEW

๐Ÿ‡บ๐Ÿ‡ธ

Providence, Rhode Island, United States

Brown University School of Public Health

๐Ÿ‡บ๐Ÿ‡ธ

Providence, Rhode Island, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath